Quantinuum (NASDAQ:QNT) Stock Price Target Lowered at Cantor Fitzgerald

Quantinuum (NASDAQ:QNT) had its price objective trimmed by Cantor Fitzgerald from $90.00 to $55.00 in a research note issued to investors on Friday morning, Marketbeat reports. The firm currently has an overweight rating on the stock.

Several other research analysts have also commented on QNT. Needham & Company LLC reiterated a “buy” rating and issued a $100.00 target price on shares of Quantinuum in a research report on Wednesday, August 12th. Morgan Stanley raised Quantinuum from an “equal weight” rating to an “overweight” rating and dropped their price target for the company from $78.00 to $62.00 in a research report on Thursday, October 15th. Sanford C. Bernstein restated a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Weiss Ratings started coverage on shares of Quantinuum in a report on Monday, August 31st. They issued a “sell (d)” rating for the company. Finally, Jefferies Financial Group set a $85.00 target price on shares of Quantinuum in a research note on Wednesday, August 12th. Thirteen analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $85.62.

Quantinuum Stock Up 26.0%

NASDAQ:QNT traded up $7.75 during mid-day trading on Friday, reaching $37.57. The stock had a trading volume of 5,036,156 shares, compared to its average volume of 2,182,406. The stock has a market cap of $9.89 billion and a P/E ratio of -134.18. Quantinuum has a 1-year low of $28.31 and a 1-year high of $86.79. The business has a 50 day simple moving average of $43.41.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million during the quarter. As a group, analysts predict that Quantinuum will post -4.76 EPS for the current fiscal year.

Institutional Trading of Quantinuum

Several hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP bought a new position in Quantinuum during the 2nd quarter worth $92,418,000. HBK Investments L P bought a new stake in Quantinuum in the second quarter valued at $14,669,000. BlueCrest Capital Management Ltd bought a new stake in Quantinuum in the second quarter valued at $14,304,000. Readystate Asset Management LP bought a new stake in Quantinuum in the second quarter valued at $4,111,000. Finally, Light Street Capital Management LLC acquired a new position in shares of Quantinuum during the second quarter valued at $2,881,000.

Quantinuum News Roundup

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

About Quantinuum

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.